Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Comparing steerable and conventional access sheaths for treating small kidney stones

Official title: Flexible Ureteroscopy With Steerable Versus Conventional Flexible and Navigable Suction Ureteral Access Sheath (FANS) Utility in Less Than 2cm Lower Pole Stones Treatment: a Multicenter, Randomized Superiority Trial (SCULPT Trial)

Run by The First Affiliated Hospital of Guangzhou Medical University · NCT06898216 · Data updated 2026-11-12

This study is testing a new flexible tool for removing small kidney stones to see if it works better and is safer than the standard method.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment400 (estimated)
SponsorThe First Affiliated Hospital of Guangzhou Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMarch 16, 2025
Main results expectedJanuary 1, 2026
Study endsMarch 1, 2026
Registry record updatedMarch 27, 2025
Trial IDNCT06898216 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-75 with a single lower pole renal stone of 2 cm or less.

Probably not a fit

Patients with anatomical abnormalities of the urinary tract or multiple stones may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized trial compares the efficacy and safety of a novel steerable flexible and navigable suction ureteral access sheath (FANS) against a conventional FANS for treating lower pole renal stones that are 2 cm or smaller. The steerable FANS features an active deflection mechanism that enhances maneuverability, potentially improving access to challenging anatomical areas. A total of 400 patients will be enrolled from 20 high-volume urological centers in China, with outcomes focusing on success rates, operative time, and complication rates. The trial aims to address the limitations of conventional methods in managing lower pole stones effectively.

Why it matters

Potential benefit: If successful, this approach could lead to improved treatment outcomes and reduced complications for patients with lower pole kidney stones.

How similar studies have gone: Other studies have shown promise in using innovative access devices for kidney stone treatment, but this specific steerable approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-75 years
* Diagnosed with a single lower pole renal stone ≤2 cm by CT
* American Society of Anesthesiology (ASA) score of 1-3
* Ability to provide written informed consent
* Willingness and ability to comply with trial procedures and follow-up

Exclusion Criteria:

* Patients with urinary tract anatomical abnormalities (e.g., horseshoe kidney, ileal conduit)
* Untreated urinary tract infection
* Presence of multiple stones or stones located outside the lower pole
* Absolute contraindications to flexible ureteroscopy
* Inability to understand or complete trial documentation

Where it's running

  • Department of Urology, The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Guohua Zeng, M.D. — The First Affiliated Hospital of Guangzhou Medical University
  • Study coordinator: Guohua Zeng, M.D.
  • Email: gzgyzgh@vip.sina.com
  • Phone: 13622754991

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.